ATLASBridgeBio Pharma (BBIO) earnings date: expected January 14–20
BridgeBio Pharma (BBIO) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around January 14–20. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on BBIO
| Last price | $74.95 (+6.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.7% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 6 reports |
These figures come from the same calibrated model and valuation as the BridgeBio Pharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 14–20 (estimate). One email the day before, with ATLAS’s read on BridgeBio Pharma. You can switch it off at any time.
Alert me before BBIO reportsFree to start. Creating an account takes under a minute.
BBIO earnings at a glance
| Next report | Not announced · expected around January 14–20 (ATLAS estimate) |
|---|---|
| Last report | Oct 29, 2026 · Beat |
| Beat rate (last 6 reports) | 3 of 6 (50%) |
| Average EPS surprise | +7.3% |
| Average move around a report | ±1.6% (last 5) |
| Sector | Healthcare · Biotechnology |
The expected window is an ATLAS estimate: it takes the typical gap between BridgeBio Pharma’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
BridgeBio Pharma earnings history: last 6 reports
BridgeBio Pharma last reported on Oct 29, 2026: EPS of -$0.42 against an estimate of -$0.60 (+30.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 29, 2026 | -$0.60 | -$0.42 | +30.0% | Beat | – |
| Aug 10, 2026 | -$0.58 | -$0.78 | -34.5% | Miss | -0.9% |
| May 7, 2026 | -$0.62 | -$0.84 | -35.5% | Miss | -1.0% |
| Feb 24, 2026 | -$0.62 | -$0.94 | -51.6% | Miss | -2.0% |
| Dec 17, 2025 | -$0.36 | $0.10 | +127.8% | Beat | -2.1% |
| Oct 29, 2025 | -$0.78 | -$0.72 | +7.7% | Beat | -1.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for BBIO
See the fair value, the probability range and the earnings history of BridgeBio Pharma on its ATLAS page.
BridgeBio Pharma (BBIO) stock analysisPlans from €3.99 a month.
BridgeBio Pharma earnings: frequently asked questions
When is BridgeBio Pharma (BBIO) next earnings date?
BridgeBio Pharma has not announced its next report. Its last 4 reports came Oct 29, 2026, Aug 10, 2026, May 7, 2026, Feb 24, 2026, so ATLAS estimates the next one around January 14–20. This is an estimate based on that pattern, not a confirmed date.
How often does BBIO beat earnings estimates?
Of its last 6 reports with a recorded result, BridgeBio Pharma beat the EPS estimate 3 times; the average surprise was +7.3%. Past results do not predict the next one.
How much does BBIO move around earnings?
Over its last 5 reports the stock moved an average of 1.6% (absolute, from the close before the report day to the close after it), and finished higher 0 of 5 times.
Did BridgeBio Pharma beat earnings estimates last quarter?
BridgeBio Pharma last reported on Oct 29, 2026: EPS of -$0.42 against an estimate of -$0.60 (+30.0% surprise), a beat.
How much does BBIO usually move in a day?
On a normal trading day the ATLAS model puts BBIO’s one-day range at about ±2.7%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer